Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Herpes zoster"" wg kryterium: Temat


Starter badań:

Tytuł :
A retrospective cohort study confirms that prophylactic vaccination is underused in patients on tumor necrosis factor inhibitors.
Autorzy :
Patel D; Penn State College of Medicine, Hershey, Pennsylvania. Electronic address: .
Maczuga S; Department of Dermatology, Penn State Hershey Medical Center, Hershey, Pennsylvania.
Helm MF; Department of Dermatology, Penn State Hershey Medical Center, Hershey, Pennsylvania.
Foulke GT; Department of Dermatology, Penn State Hershey Medical Center, Hershey, Pennsylvania.
Pokaż więcej
Źródło :
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2021 Apr; Vol. 84 (4), pp. 1150-1152. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji :
Journal Article
MeSH Terms :
Herpes Zoster Vaccine*
Influenza Vaccines*
Pneumococcal Vaccines*
Tumor Necrosis Factor Inhibitors/*therapeutic use
Vaccination/*statistics & numerical data
Guideline Adherence ; Herpes Zoster/prevention & control ; Humans ; Influenza, Human/prevention & control ; Pneumonia, Pneumococcal/prevention & control ; Practice Guidelines as Topic ; Retrospective Studies ; Risk Factors ; Tumor Necrosis Factor Inhibitors/adverse effects ; United States
Czasopismo naukowe
Tytuł :
Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials.
Autorzy :
Dagnew AF; GSK, Rockville, MD, USA.
Rausch D; GSK, Philadelphia, PA, USA.
Hervé C; GSK, Wavre, Belgium.
Zahaf T; GSK, Rixensart, Belgium.
Levin MJ; Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Schuind A; GSK, Rockville, MD, USA.
Pokaż więcej
Corporate Authors :
ZOE-50/70 study group
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2021 Mar 02; Vol. 60 (3), pp. 1226-1233.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :
Herpes Zoster Vaccine*
Herpes Zoster/*epidemiology
Aged ; Arthritis, Rheumatoid/epidemiology ; Celiac Disease/epidemiology ; Clinical Trials, Phase III as Topic ; Female ; Herpes Zoster/immunology ; Humans ; Male ; Middle Aged ; Psoriasis/epidemiology ; Randomized Controlled Trials as Topic ; Spondylarthropathies/epidemiology ; Vaccines, Synthetic
Czasopismo naukowe
Tytuł :
[Surveillance and epidemiology of Herpes Zoster in Spain.]
Autorzy :
Masa-Calles J; Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Madrid. España.; Ciber de Epidemiología y Salud Pública. Instituto de Salud Carlos III. Madrid. España.
López-Perea N; Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Madrid. España.; Ciber de Epidemiología y Salud Pública. Instituto de Salud Carlos III. Madrid. España.
Vila Cordero B; Hospital Universitario Rey Juan Carlos. Móstoles (Madrid). España.
Carmona R; Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Madrid. España.
Pokaż więcej
Transliterated Title :
Vigilancia y epidemiología del herpes zóster en España.
Źródło :
Revista espanola de salud publica [Rev Esp Salud Publica] 2021 Jun 25; Vol. 95. Date of Electronic Publication: 2021 Jun 25.
Typ publikacji :
Journal Article
MeSH Terms :
Population Surveillance*
Herpes Zoster/*epidemiology
Adolescent ; Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Herpes Zoster/mortality ; Herpes Zoster/therapy ; Herpes Zoster Vaccine/administration & dosage ; Hospitalization/statistics & numerical data ; Humans ; Incidence ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Registries ; Sex Distribution ; Spain/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines.
Autorzy :
Schmid DS; Viral Vaccine Preventable Diseases Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA .
Miao C; Viral Vaccine Preventable Diseases Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Leung J; Viral Vaccine Preventable Diseases Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Johnson M; Department of Pediatrics, University of Colorado Denver School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Weinberg A; Department of Pediatrics, University of Colorado Denver School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Medicine, University of Colorado Denver School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Pathology, University of Colorado Denver School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Levin MJ; Department of Pediatrics, University of Colorado Denver School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Medicine, University of Colorado Denver School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2021 May 24; Vol. 95 (12). Date of Electronic Publication: 2021 May 24 (Print Publication: 2021).
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Antibodies, Viral/*blood
Antibodies, Viral/*immunology
Herpes Zoster Vaccine/*immunology
Herpesvirus 3, Human/*immunology
Adjuvants, Immunologic ; Aged ; Aged, 80 and over ; Antibodies, Neutralizing/blood ; Antibodies, Neutralizing/immunology ; Antibody Affinity ; Enzyme-Linked Immunosorbent Assay ; Herpes Zoster/prevention & control ; Humans ; Immunogenicity, Vaccine ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Middle Aged ; Vaccines, Attenuated/immunology ; Vaccines, Subunit/immunology ; Vaccines, Synthetic/immunology ; Viral Envelope Proteins/immunology
Czasopismo naukowe
Tytuł :
Effect of herpes zoster vaccine and antiviral treatment on risk of ischemic stroke.
Autorzy :
Yang Q; From the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA. .; The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. .
George MG; From the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA.; The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Chang A; From the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA.; The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Tong X; From the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA.; The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Merritt R; From the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA.; The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Hong Y; From the Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta, GA.; The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 Aug 11; Vol. 95 (6), pp. e708-e717. Date of Electronic Publication: 2020 Jul 07.
Typ publikacji :
Journal Article
MeSH Terms :
Herpes Zoster Vaccine*
Antiviral Agents/*therapeutic use
Brain Ischemia/*etiology
Herpes Zoster/*complications
Age Distribution ; Aged ; Aged, 80 and over ; Brain Ischemia/epidemiology ; Brain Ischemia/prevention & control ; Ethnic Groups/statistics & numerical data ; Herpes Zoster/drug therapy ; Herpes Zoster/prevention & control ; Humans ; Male ; Medicare/statistics & numerical data ; Sex Distribution ; Stroke/etiology ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients.
Autorzy :
Chun JY; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.; Present affiliation: Department of Internal Medicine, National Cancer Center, Goyang, South Korea.
Kim K; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Lee MK; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Kang CK; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Koh Y; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Shin DY; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Hong J; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Choe PG; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Kim NJ; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Park WB; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. .
Kim I; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. .
Oh MD; Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Jan 26; Vol. 21 (1), pp. 117. Date of Electronic Publication: 2021 Jan 26.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/statistics & numerical data
Herpes Zoster Vaccine*/adverse effects
Herpes Zoster Vaccine*/immunology
Transplant Recipients*/statistics & numerical data
Vaccines, Live, Unattenuated*/adverse effects
Vaccines, Live, Unattenuated*/immunology
Herpes Zoster/*prevention & control
Herpesvirus 3, Human/*immunology
Aged ; Antibodies, Viral/immunology ; Case-Control Studies ; Female ; Follow-Up Studies ; Hematologic Neoplasms/epidemiology ; Hematologic Neoplasms/immunology ; Hematologic Neoplasms/therapy ; Humans ; Immunogenicity, Vaccine/physiology ; Male ; Middle Aged ; Treatment Outcome ; Vaccination/adverse effects ; Vaccination/methods ; Vaccination/statistics & numerical data
Czasopismo naukowe
Tytuł :
Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals.
Autorzy :
Curran D; GSK, Wavre, Belgium.
Kim JH; GSK, Rockville, Maryland, USA.
Matthews S; Freelance c/o GSK, Wavre, Belgium.
Dessart C; GSK, Wavre, Belgium.
Levin MJ; Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Oostvogels L; GSK, Wavre, Belgium.
Riley ME; GSK, Rockville, Maryland, USA.
Schmader KE; Division of Geriatrics, Duke University Medical Center and GRECC, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA.
Cunningham AL; The Westmead Institute for Medical Research, Westmead, University of Sydney, Sydney, Australia.
McNeil SA; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Canada.
Schuind AE; GSK, Rockville, Maryland, USA.
Andrew MK; Division of Geriatric Medicine, Department of Medicine, Dalhousie University, Halifax, Canada.
Pokaż więcej
Corporate Authors :
Zoster-064 Study Group
Źródło :
Journal of the American Geriatrics Society [J Am Geriatr Soc] 2021 Mar; Vol. 69 (3), pp. 744-752. Date of Electronic Publication: 2020 Nov 16.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Frail Elderly/*statistics & numerical data
Herpes Zoster Vaccine/*adverse effects
Aged ; Aged, 80 and over ; Female ; Herpes Zoster/immunology ; Herpes Zoster/prevention & control ; Herpes Zoster Vaccine/administration & dosage ; Herpes Zoster Vaccine/immunology ; Humans ; Male ; Middle Aged ; Vaccination/statistics & numerical data ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/adverse effects ; Vaccines, Synthetic/immunology
Czasopismo naukowe
Tytuł :
Insurance reimbursements for recombinant zoster vaccine in the private sector.
Autorzy :
Leidner AJ; National Center for Immunization and Respiratory Diseases, CDC, United States of America. Electronic address: .
Tang Z; Berry Technology Solutions, Contractor for National Center for Immunization and Respiratory Diseases, CDC, United States of America.
Guo A; Strategic Innovative Solutions, Contractor for National Center for Immunization and Respiratory Diseases, CDC, United States of America.
Anderson TC; National Center for Immunization and Respiratory Diseases, CDC, United States of America.
Tsai Y; National Center for Immunization and Respiratory Diseases, CDC, United States of America.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Aug 23; Vol. 39 (36), pp. 5091-5094. Date of Electronic Publication: 2021 Aug 02.
Typ publikacji :
Journal Article
MeSH Terms :
Herpes Zoster*/prevention & control
Herpes Zoster Vaccine*
Insurance*
Adult ; Humans ; Middle Aged ; Private Sector ; United States ; Vaccines, Synthetic
Czasopismo naukowe
Tytuł :
The role of social determinants in timely herpes zoster vaccination among older American adults.
Autorzy :
Shuvo S; College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, TN, USA.
Hagemann T; College of Pharmacy, University of Tennessee, Nashville, TN, USA.
Hohmeier K; College of Pharmacy, University of Tennessee, Nashville, TN, USA.
Chiu CY; College of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Ramachandran S; School of Pharmacy, University of Mississippi, Oxford, MS, USA.
Gatwood J; College of Pharmacy, University of Tennessee, Nashville, TN, USA.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jul 03; Vol. 17 (7), pp. 2043-2049. Date of Electronic Publication: 2021 Jan 30.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Herpes Zoster*/epidemiology
Herpes Zoster*/prevention & control
Herpes Zoster Vaccine*
Adult ; Aged ; Humans ; Male ; Medicare ; Middle Aged ; Social Determinants of Health ; United States/epidemiology ; Vaccination
Czasopismo naukowe
Tytuł :
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials.
Autorzy :
Kim JH; GSK, Rockville, MD, USA.
Diaz-Decaro J; GSK, Rockville, MD, USA.
Jiang N; GSK, Beijing, China.
Hwang SJ; Department of Family Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan.; National Yang Ming University School of Medicine, Taipei City, Taiwan.
Choo EJ; Department of Infectious Diseases, SoonChunhyang University Bucheon Hospital, Bucheon-si, Republic of Korea.
Co M; GSK, Wavre, Belgium.
Hastie A; GSK, Rockville, MD, USA.
Hui DSC; Department of Medicine and Therapeutics, The Chinese University of Hong Kong Prince of Wales Hospital, Sha Tin, Hong Kong.
Irimajiri J; Department of Dermatology, Shonan Kamakura General Hospital, Kanagawa, Japan.
Lee J; Department of Internal Medicine, Division of Infectious Diseases, Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.
Leung EM; Department of Medicine and Geriatrics, Division of Geriatric Medicine and Rehabilitation, United Christian Hospital, Kwun Tong, Hong Kong.
Tang H; GSK, Shanghai, China.
Tsuru T; Medical CO.LTA PS Clinic, Fukuoka, Japan.
Watson P; GSK, Middlesex, UK.
Wu Z; GSK, Beijing, China.
Yu CJ; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.; National Taiwan University Hospital Biomedical Park Branch Hospital, Zhubei City, Hsinchu County, Taiwan.
Yuan Y; GSK, Beijing, China.
Zahaf T; GSK, Wavre, Belgium.
Cunningham AL; The Westmead Institute for Medical Research, Westmead, Australia.; University of Sydney, Sydney, Australia.
Schuind A; GSK, Rockville, MD, USA.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jul 03; Vol. 17 (7), pp. 2050-2057. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Clinical Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Herpes Zoster*/prevention & control
Herpes Zoster Vaccine*/adverse effects
Neuralgia, Postherpetic*/prevention & control
Adult ; Cohort Studies ; Herpesvirus 3, Human ; Humans ; Middle Aged ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
Effect of the varicella vaccination implementation on the development of herpes zoster in children and adolescents.
Autorzy :
Inan Yuksel E; Department of Dermatology, Firat University Faculty of Medicine, Elazıg, Turkey.
Kara Polat A; Department of Dermatology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey.
Gore Karaali M; Department of Dermatology, Erzincan Binali Yıldırım University Faculty of Medicine, Mengücek Gazi Training and Research Hospital, Erzincan, Turkey.
Koku Aksu AE; Department of Dermatology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey.
Gurel MS; Department of Dermatology, Medeniyet University, Faculty of Medicine, Istanbul, Turkey.
Pokaż więcej
Źródło :
Dermatologic therapy [Dermatol Ther] 2021 Jul; Vol. 34 (4), pp. e14995. Date of Electronic Publication: 2021 May 31.
Typ publikacji :
Journal Article
MeSH Terms :
Chickenpox*/epidemiology
Chickenpox*/prevention & control
Herpes Zoster*/epidemiology
Herpes Zoster*/prevention & control
Herpes Zoster Vaccine*
Adolescent ; Chickenpox Vaccine ; Child ; Herpesvirus 3, Human ; Humans ; Incidence ; Vaccination
Czasopismo naukowe
Tytuł :
Risk of herpes zoster infection in men with varicocele.
Autorzy :
Hsu CY; Department of Medical Education, Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Chia-Yi, Taiwan.; Department of Optometry, Central Taiwan University of Science and Technology, Taichung, Taiwan.; Center for General Education, National Taichung University of Science and Technology, Taichung, Taiwan.; Department of General Education, National Chin-Yi University of Technology, Taichung, Taiwan.; Rural Generalist Program Japan, GENEPRO, Asahi Shi, Japan.
Ke DS; Department of Medical Education, Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Chia-Yi, Taiwan.
Lin CL; Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan.; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
Kao CH; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan.; Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan.; Center of Augmented Intelligence in Healthcare, China Medical University Hospital, Taichung, Taiwan.
Pokaż więcej
Źródło :
Postgraduate medicine [Postgrad Med] 2021 Aug; Vol. 133 (6), pp. 599-603. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji :
Journal Article
MeSH Terms :
Cost of Illness*
Herpes Zoster*/diagnosis
Herpes Zoster*/epidemiology
Quality of Life*
Varicocele*/diagnosis
Varicocele*/epidemiology
Varicocele*/psychology
Adult ; Age Factors ; Cohort Studies ; Correlation of Data ; Humans ; Male ; Middle Aged ; Prevalence ; Risk Assessment ; Risk Factors ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
Short-Term Peripheral Nerve Stimulation Relieve Pain for Elder Herpes Zoster Ophthalmicus Patients: A Retrospective Study.
Autorzy :
Wan CF; Pain Department of the First Affiliated Hospital to China Medical University, Shenyang, China.
Song T; Pain Department of the First Affiliated Hospital to China Medical University, Shenyang, China.
Pokaż więcej
Źródło :
Neuromodulation : journal of the International Neuromodulation Society [Neuromodulation] 2021 Aug; Vol. 24 (6), pp. 1121-1126. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article
MeSH Terms :
Herpes Zoster Ophthalmicus*/complications
Herpes Zoster Ophthalmicus*/therapy
Neuralgia*
Neuralgia, Postherpetic*/therapy
Aged ; Humans ; Peripheral Nerves ; Retrospective Studies
Czasopismo naukowe
Tytuł :
[Zoster disease after Shingrix vaccination].
Autorzy :
Kohn D; Klinik für Dermatologie, Dermatochirurgie und Allergologie, Asklepios Klinik Weißenfels, Naumburger Str. 76, 06667, Weißenfels, Deutschland. .
Wetzig T
Pokaż więcej
Transliterated Title :
Zostererkrankung nach Shingrix-Impfung.
Źródło :
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete [Hautarzt] 2021 Aug; Vol. 72 (8), pp. 729-732. Date of Electronic Publication: 2020 Dec 08.
Typ publikacji :
Journal Article
MeSH Terms :
Herpes Zoster*/prevention & control
Herpes Zoster Vaccine*/adverse effects
Neuralgia, Postherpetic*/etiology
Neuralgia, Postherpetic*/prevention & control
Germany ; Humans ; Vaccination/adverse effects
Czasopismo naukowe
Tytuł :
No Association Between DAA Treatment for HCV Infection and Herpes Zoster Infection in Analysis of Data From 37 Clinical Trials.
Autorzy :
Rohde MD; Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Tracy L; Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Komatsu TE; Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
El-Kamary SS; Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Carter W; Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland. Electronic address: .
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2021 Aug; Vol. 19 (8), pp. 1670-1678. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Coinfection*/drug therapy
Hepatitis C*/complications
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Herpes Zoster*/drug therapy
Herpes Zoster*/epidemiology
Adult ; Antiviral Agents/adverse effects ; Female ; Hepacivirus ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease.
Autorzy :
Kochhar GS; Division of Gastroenterology, Hepatology & Nutrition, Allegheny Health Network, Pittsburgh, PA, USA.
Desai A; Division of Gastroenterology, Hepatology & Nutrition, Metro Health Hospital, Cleveland, OH, USA.
Caldera DO F; Division of Gastroenterology & Hepatology, University of Wisconsin School of Medicine & Public Health Madison, WI, USA.
El Hachem S; Division of Gastroenterology, Hepatology & Nutrition, Allegheny Health Network, Pittsburgh, PA, USA.
Aoun E; Division of Gastroenterology, Hepatology & Nutrition, Allegheny Health Network, Pittsburgh, PA, USA.
Sandhu D; Division of Gastroenterology, Hepatology & Nutrition, Metro Health Hospital, Cleveland, OH, USA.
Mohan BP; Internal Medicine, University of Arizona, Banner University Medical Center, Tuscon, AZ, USA.
Dulai PS; Division of Gastroenterology, Hepatology & Nutrition, University of California, San Diego, CA, USA.
Farraye FA; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jul 05; Vol. 39 (30), pp. 4199-4202. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :
Journal Article
MeSH Terms :
Herpes Zoster*/prevention & control
Herpes Zoster Vaccine*
Inflammatory Bowel Diseases*
Herpesvirus 3, Human ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Impact of pharmacist intervention on completion of recombinant zoster vaccine series in a community pharmacy.
Autorzy :
Tyler R
Kile S
Strain O
Kennedy CA
Foster KT
Pokaż więcej
Źródło :
Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2021 Jul-Aug; Vol. 61 (4S), pp. S12-S16. Date of Electronic Publication: 2020 Oct 09.
Typ publikacji :
Journal Article
MeSH Terms :
Herpes Zoster*
Herpes Zoster Vaccine*
Pharmacies*
Humans ; Pharmacists ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Effectiveness of CT-guided epidural infiltration of steroids and local anesthetics for acute and chronic herpes zoster neuralgia.
Autorzy :
Beydoun N; University Hospital of Poitiers, Department of Radiology, 86021, Poitiers, France.
Brunner P; Princess Grace Hospital, Department of Radiology, 98000, Monaco.
De La Torre Y; University Hospital of Poitiers, Department of Radiology, 86021, Poitiers, France.
Herpe G; University Hospital of Poitiers, Department of Radiology, 86021, Poitiers, France.
Guillevin R; University Hospital of Poitiers, Department of Radiology, 86021, Poitiers, France.
Ingrand P; University of Poitiers, Clinical research center, CIC 1402, 86021, Poitiers, France.
Tasu JP; University Hospital of Poitiers, Department of Radiology, 86021, Poitiers, France; LATim, Laboratory of Medical Information Processing-inserm UMR 1101, 29609 Brest cedex, France. Electronic address: .
Pokaż więcej
Źródło :
Diagnostic and interventional imaging [Diagn Interv Imaging] 2021 Sep; Vol. 102 (9), pp. 525-530. Date of Electronic Publication: 2021 Mar 27.
Typ publikacji :
Journal Article
MeSH Terms :
Herpes Zoster*
Neuralgia*/drug therapy
Neuralgia, Postherpetic*/drug therapy
Adult ; Aged ; Aged, 80 and over ; Anesthetics, Local ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Steroids ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Improvement of acyclovir-resistant herpes zoster infection by amenamevir.
Autorzy :
Onaka T; Department of Hematology, Kokura Memorial Hospital, Kitakyushu, Japan.
Shiraki K; Senri Kinran University, Osaka, Japan.
Yonezawa A; Department of Hematology, Kokura Memorial Hospital, Kitakyushu, Japan.
Pokaż więcej
Źródło :
The Journal of dermatology [J Dermatol] 2021 Sep; Vol. 48 (9), pp. e478-e479. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :
Letter
MeSH Terms :
Acyclovir*/therapeutic use
Herpes Zoster*/diagnosis
Herpes Zoster*/drug therapy
Antiviral Agents/therapeutic use ; Humans ; Oxadiazoles/therapeutic use
Opinia redakcyjna
Tytuł :
Transverse myelitis caused by varicella-zoster.
Autorzy :
Sebastian AP; Internal Medicine, Bangalore Baptist Hospital, Bangalore, Karnataka, India .
Basu A; Internal Medicine, Bangalore Baptist Hospital, Bangalore, Karnataka, India.
Mitta N; Department of Neurology, Bangalore Baptist Hospital, Bangalore, Karnataka, India.
Benjamin D; Internal Medicine, Bangalore Baptist Hospital, Bangalore, Karnataka, India.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 Aug 30; Vol. 14 (8). Date of Electronic Publication: 2021 Aug 30.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Chickenpox*
Epstein-Barr Virus Infections*
Herpes Zoster*/complications
Herpes Zoster*/diagnosis
Herpes Zoster*/drug therapy
Myelitis*
Myelitis, Transverse*/diagnosis
Myelitis, Transverse*/drug therapy
Myelitis, Transverse*/etiology
Adult ; Herpesvirus 3, Human ; Herpesvirus 4, Human ; Humans ; Male
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies